- Design
- randomised, controlled, blinded, multicentre superiority trial, two French tertiary hospitals, 2021-2023
- Population
- 320 adults undergoing elective cardiac surgery with cardiopulmonary bypass, mean age 66.4 years, 77.2% men
- Primary outcome
- composite of neurological, respiratory, cardiovascular or renal complications, or death, within 30 days
- Effect
- 75.4% vs 84.5%, RR 0.90 (95% CI 0.80 to 0.99), P = 0.049; fragility index 1
OFACAR randomised 320 adults having elective cardiac surgery with cardiopulmonary bypass at two French tertiary hospitals to an opioid-free technique — intravenous ketamine, dexamethasone, lidocaine and magnesium sulfate — or to sufentanil. The primary endpoint was a 30-day composite of neurological, respiratory, cardiovascular or renal complications, or death. It occurred in 75.4% of the opioid-free group and 84.5% of the control group (RR 0.90, 95% CI 0.80 to 0.99, P = 0.049).
The honest reading is in the fragility index, which was 1. One patient moving between groups would have taken the result across the line into non-significance. The investigators say plainly that the finding is hypothesis-generating and needs a larger trial. Two component results are harder to dismiss: digestive complications fell from 11.2% to 2.5% (RR 0.22, 95% CI 0.08 to 0.65), and there were no deaths in the opioid-free arm against six in the control arm.
So this is not yet a reason to rewrite a cardiac anaesthesia protocol, but it is a reason to stop treating opioid-free technique in this population as unproven in principle. The event rate is the striking number: more than three-quarters of patients in both arms met the composite. A composite that common is easy to move and hard to interpret, and the mortality and gastrointestinal signals deserve a trial powered to test them directly.
- Record which components of any composite you are actually trying to prevent before adopting a technique on composite evidence
- If trialling the regimen, the tested combination was ketamine, dexamethasone, lidocaine and magnesium sulfate — not any opioid-sparing mixture
- Watch postoperative ileus and gastrointestinal recovery, where the largest single effect sat
- Baseline complication rates above 75% mean your own case mix may behave differently; audit locally before and after
- Blinded but two-centre and elective only — do not extend to emergency or redo bypass surgery on this evidence
The statistics, in plain English
A fragility index of 1 means the entire result rests on a single patient's outcome; had one more opioid-free patient had a complication, P would have exceeded 0.05. The upper confidence limit of 0.99 sits almost exactly on no effect, so the data are compatible with a benefit anywhere from substantial to negligible. The mortality difference (0 vs 6) was not the primary endpoint and comes from small numbers, so it is a signal to test rather than an effect size to quote.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free